- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Torrent Pharmaceuticals Limited — Updates, 21-03-2026: Press Release
21-03-2026 | 02:00 pm
21-03-2026 | 02:00 pm
Torrent Pharma launched Semaglutide (Sembolic, Semalix) in India, including the first generic oral formulation. The injectable version starts at Rs. 3,999/month, expanding its presence in the significant type-2 diabetes and obesity market.
No comments yet. Be the first to comment!